arrow
返回

Genetic Modification of Limbal Stem Cells to Decrease Allogeneic Immune Responses

delete2021-12-09
delete5
delete
OA
AI
E
Emilio Valdivia
M
Marina Bertolin
C
Claudia Breda
M
Marco Carvalho Oliveira
A
Anna Katharina Salz
N
Nicola Hofmann
M
Martin Börgel
R
Rainer Blasczyk
S
Stefano Ferrari
C
Constança Figueiredo *
DOI:10.3389/fimmu.2021.747357delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Limbal stem cell (LSC) transplantation is the only efficient treatment for patients affected by LSC deficiency (LSCD). Allogeneic LSC transplantation is one of the most successful alternative for patients with bilateral LSCD. Nevertheless, the high variability of the human leukocyte antigens (HLA) remains a relevant obstacle to long-term allogeneic graft survival. This study characterized the immunologic properties of LSCs and proposed a genetic engineering strategy to reduce the immunogenicity of LSCs and of their derivatives. Hence, LSC HLA expression was silenced using lentiviral vectors encoding for short hairpin (sh) RNAs targeting beta 2-microglobulin (beta 2M) or class II major histocompatibility complex transactivator (CIITA) to silence HLA class I and II respectively. Beside the constitutive expression of HLA class I, LSCs showed the capability to upregulate HLA class II expression under inflammatory conditions. Furthermore, LSCs demonstrated the capability to induce T-cell mediated immune responses. LSCs phenotypical and functional characteristics are not disturbed after genetic modification. However, HLA silenced LSC showed to prevent T cell activation, proliferation and cytotoxicity in comparison to fully HLA-expressing LSCs. Additionally; HLA-silenced LSCs were protected against antibody-mediated cellular-dependent cytotoxicity. Our data is a proof-of-concept of the feasibility to generate low immunogenic human LSCs without affecting their typical features. The use of low immunogenic LSCs may support for long-term survival of LSCs and their derivatives after allogeneic transplantation.
Keyword:
limbal stem cell
RNA interference
HLA
limbal stem cell deficiency
allotransplantation
lentiviral vector
gene therapy
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

Frontiers in Immunology 封面图
Frontiers in Immunology
IF:
5.9
论文数:
5.3W
被引数:
29.8W

机构

暂无机构信息
引用论文

引用论文

Development of Dual-Aptamers for Constructing Sandwich-Type Pancreatic Polypeptide Assay
err2017-02-02
err0
PREAI
errShiya Qin; Nandi Chen; Xiaohai Yang; Qing Wang; Kemin Wang; Jin Huang; Jianbo Liu; Maogui Zhou
err分享
err收藏
Corneal graft rejection
err2007-07-01
err231
PREAI
errPanda, Anita; Vanathi, M.; Kumar, A.; Dash, Yeshoda; Priya, Satya
err分享
err收藏
Silencing HLA Class I Expression in Human Corneas to Decrease the Risk of Graft Rejection after Keratoplasty
err2012-11-01
err1
errOAAI
errFigueiredo, C.; Vahlsing, S.; Valtink, M.; Boergel, M.; Engelmann, K.; Blasczyk, R.
err分享
err收藏
Location and clonal analysis of stem cells and their differentiated progeny in the human ocular surface
err1999-05-17
err644
errOAAI
errPellegrini, G; Golisano, O; Paterna, P; Lambiase, A; Bonini, S; Rama, P; De Luca, M
err分享
err收藏
Alloimmune T cells in transplantation
err2017-06-19
err94
errOAAI
errDeWolf, Susan; Sykes, Megan
err分享
err收藏
IL-17 Promotes Immune Privilege of Corneal Allografts
err2010-10-15
err33
errOAAI
errCunnusamy, Khrishen; Chen, Peter W.; Niederkorn, Jerry Y.
err分享
err收藏
Systemic immunosuppression in limbal stem cell transplantation: best practices and future challenges
err2018-08-01
err16
PREAI
errBallios, Brian G.; Weisbrod, Maxwell; Chan, Clara C.; Borovik, Armand; Schiff, Jeffrey R.; Tinckam, Kathryn J.; Humar, Atul; Kim, S. Joseph; Cole, Edward H.; Slomovic, Allan R.
err分享
err收藏
Xenofree generation of limbal stem cells for ocular surface advanced cell therapy
err2019-12-04
err10
errOAAI
errNieto-Nicolau, Nuria; Martinez-Conesa, Eva M.; Velasco-Garcia, Alba M.; Aloy-Reverte, Caterina; Vilarrodona, Anna; Casaroli-Marano, Ricardo P.
err分享
err收藏
学者 查看更多内容